Updates in Lupus Clinical Research from the LUPUS 2019 Meeting
April 11, 2019
The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS...
lupus research alliance
New Treatment Approaches Supported by LRA Were Highlighted at LUPUS 2019
April 11, 2019
The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has...
Thank You Congress for Hearing Our Lupus Advocates!
March 28, 2019
Thank you to the Congressional Lupus Caucus Co-chairs for leading, and to all the Representatives who signed...
Lupus Research Alliance Earns Coveted 4-Star Rating from Charity Navigator
NEW YORK, NY. March 28 – Lupus Research Alliance earned a 4-star rating from Charity Navigator, America’s largest independent...
NOT TOO LATE: Join Our 15th Annual Advocate for Lupus Research Day – THROUGH NEXT WEEK!
Lupus purple was seen throughout the Capitol this week when advocates representing the Lupus Research Alliance visited Congress to...
Lupus Research Alliance Advocates Call on Congress to Fund More Lupus Scientific Exploration
WASHINGTON, DC – March 19. Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, celebrates its...
Thank you 2019 Half-Marathon Team Life Without Lupus!
Thanks to the Lupus Research Alliance Team Life Without Lupus, with runners who pounded the pavements at the United...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs...
Lupus Therapeutics to Test Potential Treatment for Lupus in Takeda Collaboration
New York, NY– March 1. The Lupus Research Alliance and clinical affiliate, Lupus Therapeutics will partner with Takeda Pharmaceutical Company...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success
February 28, 2019
NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...
Positive Early Results for BIIB059 as New Treatment Strategy
February 28, 2019
Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...